Coronavirus Live Count Map India
remove_red_eye 536 Views
COVID-19 Vaccine Updates
#Business And Medicine #Emergency Medicine #Infectious Diseases #Pathology and Lab Medicine #Pharmacist #Public Health #Pulmonary Medicine
Johnson & Johnson has stated that it will resume the rollout of its COVID-19 vaccine in Europe after the medical regulator mentioned that the benefits of the vaccine outweigh the risk of very rare, potentially lethal blood clots.
The European Medicines Agency (EMA) has recommended that a warning regarding rare blood clots with low platelet count be added to the vaccine’s product label and stated that the benefits of the single-dose vaccine outweigh its risks.
J&J vaccine rollout was temporarily paused by U.S. regulators last week following reports of rare brain blood clots along with low blood platelet count in six women, which made the company delay its rollout in Europe… (Reuters, April 20, 2021)